DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high‐risk disease

Abstract excerpt

Myeloid neoplasms with germline DDX41 mutations have been incorporated into the 2017 WHO classification. Limited studies describing the clinicopathologic features and mutation profile are available. We searched for myeloid neoplasms with a DDX41 gene mutation tested by an 81-gene next-generation sequencing panel over a 7-month period. We identified 34 patients with myeloid neoplasms with DDX41 abnormalities; 26...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acute Myeloid Leukemia Research
• Share to Lymphoma Diagnosis and Treatment
• Share to Myeloproliferative Neoplasms: Diagnosis and Treatment